CM1, a possible novel activation molecule on human lymphocytes

Area of Science:

• Immunology
• Cell Biology

Background:

• Germinal centers (GCs) are crucial for B cell maturation and antibody diversification.
• Identifying specific markers for GC B cell subsets aids in understanding B cell differentiation pathways.

Purpose of the Study:

• To characterize a novel molecule, CM1 (centrocyte/-blast marker 1), expressed on tonsillar germinal center B cells.
• To investigate the function and localization of CM1 in B cell populations.

Main Methods:

• Monoclonal antibody (mAb) development against concanavalin-A activated peripheral blood mononuclear cells (PBMCs).
• Single flow cytometry, western blot, immunoprecipitation, and immunohistochemical staining.
• Cross-linking of CM1 with anti-CM1 mAb to assess functional effects.

Main Results:

• CM1 is specifically expressed on some tonsillar germinal center B cells, not in bone marrow, PBMCs, or thymocytes.
• Peripheral B lymphocytes showed >90% positivity post-activation, while T lymphocytes showed ~60% positivity.
• Western blot and immunoprecipitation identified CM1 at 70 kDa.
• CM1 cross-linking induced apoptosis in CD38(+)IgD(-) GC B cells.
• Immunohistochemistry showed CM1 distributed throughout GC areas, excluding the dark zone.

Conclusions:

• CM1 is a novel marker for centrocyte/-blast differentiation.
• CM1 expression and its ability to induce apoptosis suggest a role in germinal center B cell differentiation.